Advances in fluorescent sensing carbon dots: An account of food analysis

J Tian, M An, X Zhao, Y Wang, M Hasan - ACS omega, 2023 - ACS Publications
Illuminating the use of nanomaterials, carbon quantum dots (CQDs) have transfigured the
food safety arena because of their bright luminescence, optical properties, low toxicity, and …

Therapeutic drug monitoring of targeted anticancer protein kinase inhibitors in routine clinical use: a critical review

E Cardoso, M Guidi, B Blanchet… - Therapeutic drug …, 2020 - journals.lww.com
Background: Therapeutic response to oral targeted anticancer protein kinase inhibitors
(PKIs) varies widely between patients, with insufficient efficacy of some of them and …

Peripheral blood mononuclear cell derived biomarker detection using eXplainable Artificial Intelligence (XAI) provides better diagnosis of breast cancer

S Kumar, A Das - Computational Biology and Chemistry, 2023 - Elsevier
The incidence and mortality rate of breast cancer increases yearly by an average of 1.44%
and 0.23%, respectively. Till 2021, there were 7.8 million women who had been diagnosed …

Improving therapeutic decisions: pharmacodynamic monitoring as an integral part of therapeutic drug monitoring

M Shipkova, U Christians - Therapeutic drug monitoring, 2019 - journals.lww.com
Although the monitoring of drug therapies based on the determination of drug
concentrations in biological materials is certainly an important instrument for individualized …

Simultaneous quantification of pirarubicin, doxorubicin, cyclophosphamide, and vincristine in human plasma of patients with non-Hodgkin's lymphoma by LC–MS/MS …

P Qi, P Li, L Qiao, H Xue, Y Ma, S Wei, X Yang… - … of Chromatography B, 2023 - Elsevier
Abstract Pirarubicin (THP), doxorubicin (DOX), cyclophosphamide (CTX), and vincristine
(VCR) are widely used in the treatment of patients with non-Hodgkin's Lymphoma. Herein, a …

Therapeutic drug monitoring guidelines in oncology: what do we know and how to move forward? Insights from a systematic review

X Li, Z Song, Z Yi, J Qin, D Jiang… - Therapeutic …, 2024 - journals.sagepub.com
Background: Compared with anti-infective drugs, immunosuppressants and other fields, the
application of therapeutic drug monitoring (TDM) in oncology is somewhat limited. Objective …

Liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS) methods for the therapeutic drug monitoring of cytotoxic anticancer drugs: An update

M Briki, A Murisier, M Guidi, C Seydoux, T Buclin… - … of Chromatography B, 2024 - Elsevier
In the era of precision medicine, there is increasing evidence that conventional cytotoxic
agents may be suitable candidates for therapeutic drug monitoring (TDM)-guided drug …

Feasibility and early clinical impact of precision medicine for late-stage cancer patients in a regional public academic hospital

M Ladekarl, AK Nøhr, M Sønderkær, SC Dahl… - Acta …, 2023 - Taylor & Francis
Aim Our goal was to describe a precision medicine program in a regional academic hospital,
characterize features of included patients and present early data on clinical impact …

Therapeutic Drug Monitoring as a Tool for Therapy Optimization

M Babu, K Pavithran - Drug Metabolism and Bioanalysis Letters …, 2022 - ingentaconnect.com
The use of pharmacotherapy for improving healthcare in society is increasing. A vast
majority of patients have either received subtherapeutic treatment (which could result from …

Terapijsko praćenje lijekova kao način poboljšanja ishoda onkološke terapije

L Turković, Z Mlinarić, T Silovski… - Farmaceutski …, 2022 - repozitorij.pharma.unizg.hr
Rak je, nakon kardiovaskularnih bolesti, drugi vodeći uzrok smrtnosti u svijetu. Procjene o
učestalosti i smrtnosti za 10 najčešćih sijela raka u 2020. godini na temelju podataka …